The next big thing


Innovation Fields

At the Innovation Center, we are investing in forward-looking ideas. By analyzing current mega-trends, we identify Innovation Fields in which we see potential for new business.

Our Innovation Field “Cultured Meat” – also referred to as clean, cultivated or cell-based meat – focuses on the biotechnology required to produce genuine meat and seafood grown in vitro. This will enable the production of animal protein that is healthier, more ethical and environmentally sustainable. As a leading supplier to the biopharma industry and through our expertise in cell line engineering, culture media and bioprocessing technologies, we aim to become a technology enabling partner for the cultured meat industry – from R&D to the efficient scale-up of cultured meat production. By working with companies who are looking to commercialize clean meat, we offer our knowledge and production skills to help them to overcome critical technological challenges.

Imagine the possibilities!

  • Eat meat without guilt: cultured meat production will use less land and water, generate lesser greenhouse gases and remove animal suffering
  • Better nutrition: Chicken with an extra boost of vitamins, beef enriched with omega-3 or mercury-free tuna

 

What are we looking for?

  • Technologies to enable economically viable, large-scale production of cultured meat and seafood such as animal component-free media, high-yield cell line development, industrial bioreactors or automation platforms
  • Technologies similar to tissue engineering and regenerative medicine, to enable next-generation of structured meat products such as edible scaffolds/biomaterials, 3D cell culture processes or 3D printing

Want to learn more? Have a look at this background story about Clean Meat. Curious to know the science behind cultured meat and what it takes to bring it to the dinner tables of consumers? Join our upcoming Innovators´ Club online edition to find out!

 

With the recent advent of liquid biopsy as a new sampling and testing method, non-invasive alternatives to traditional tissue-based diagnostics are beginning to be applied more and more in clinical contexts, thereby reshaping the way of detecting and managing various diseases. Our Innovation Field “Liquid Biopsy Technologies” focuses on technological solutions to overcome unresolved challenges in the liquid biopsy workflow as well as on applications beyond cancer.

Imagine the possibilities!

  • Non-invasive diagnosis and patient monitoring
  • Individualized treatment selection in cancer and beyond
  • Detection of diseases early before symptoms appear

 

What are we looking for?

  • New technologies that help overcome bottlenecks in the liquid biopsy workflow such as the isolation of specific body fluid components or biomarkers
  • Liquid biopsies for indications beyond oncology where existing diagnosis or surveillance methods are inadequate and have significant limitations due to their invasiveness 

Curious to get to know one of our innovation projects within this field? Click here to learn about a novel research use only kit that enables scientists to test out the potential of a biomarker for kidney inflammation monitoring.

Create the NEXT BIG THING with us

We are looking for partnerships to create sustainable new businesses within our Innovation Fields. Interested?

Stay up-to-date!

Click here to subscribe to our e-mail service and get news from our Innovation Center!

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement